Last reviewed · How we verify
NCT07096180
Clinical Observational Studies:Integrative TCM and Western Medicine for Breast Cancer
trial testing Chemotherapy drug in Breast Cancer in 200 participants. Currently enrolling.
31 December 2026
Quick facts
| Lead sponsor | Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation |
|---|---|
| Status | Recruiting now |
| Study type | OBSERVATIONAL |
| Enrollment | 200 |
| Start date | 1 January 2024 |
| Primary completion | 31 December 2026 |
| Estimated completion | 31 December 2026 |
| Sites | 1 location across Taiwan |
Drugs / interventions tested
- Chemotherapy drug — full drug profile →
- Integrative Treatment (Chemotherapy + TCM)
Conditions studied
- Breast Cancer — all drugs for Breast Cancer →
Sponsor
Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation
Who can join
18 and older, female only, with Breast Cancer. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The aim of this study is to investigate the intervention of traditional Chinese medicine (TCM) in managing the side effects experienced by breast cancer patients undergoing conventional Western medical treatments, such as blood cell decline, nausea, vomiting, gastrointestinal discomfort, and overall quality of life. The study aims to establish a long-term clinical enrollment criteria and process for TCM adjuvant therapy in breast cancer. The research design will utilize a prospective cohort study and real-world cross-sectional observational research method to obtain clinical data and survival status of the patients.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07096180
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Chemotherapy drug
Trials testing the same drug.
- NCT05798845 — The Effect of Toripalimab Plus Radiotherapy in Patients With Operable Stage II-IIIA (N+) Non Small Cell Lung Cancer · Phase 2 · recruiting
- NCT06841952 — Study of Tretinoin Capsules in Combination With Azacitidine and Venetoclax in Treatment Naïve Participants With Acute My · NA · not yet recruiting
- NCT06446388 — Study of QLS31905 and/or QL1706 Combination With Chemotherapy in the Advanced Malignant Solid Tumors · Phase 2 · not yet recruiting
- NCT06840119 — Phase 1/2 Study of IMC-R117C in Selected Advanced Cancers · Phase 1, PHASE2 · recruiting
- NCT05892237 — CIETAI and Sequential Radiotherapy in Squamous Lung Cancer · Phase 2 · recruiting
Other recruiting trials for Breast Cancer
Currently open trials in the same condition.
- NCT06148038 — CBD for Breast Cancer Primary Tumors · Phase 1 · recruiting
- NCT07405801 — A Phase II Study Evaluating the Efficacy and Safety of Inavolisib Plus Ribociclib Plus Fulvestrant Versus Placebo Plus R · Phase 2 · recruiting
- NCT07285993 — Detection and Outcomes in Metastatic Invasive Lobular Breast Cancer Through Novel F-18 FAP PET · Phase 2 · recruiting
- NCT07510698 — Same-Day Awake Mastectomy With Immediate Breast Reconstruction for Patients With Breast Cancer · NA · recruiting
- NCT06768931 — Biolosion Combined Standard Neoadjuvant Therapy to Treat Triple-negative Breast Cancer · Phase 2 · recruiting
Other Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation trials
Trials by the same sponsor.
- NCT07357142 — Jing Si Herbal Tea as Adjuvant Treatment in Patients With Chronic Pelvic Pain Syndrome · NA · not yet recruiting
- NCT07310797 — Comparison of Mirabegron and Tamsulosin for Ureteral Stone Expulsion · Phase 4 · not yet recruiting
- NCT07472803 — Longitudinal Body Composition Assessment in Breast Cancer Patients · recruiting
- NCT07151963 — Effects of Prolonged Continuous Theta Burst Stimulation in Chemotherapy-induced Peripheral Neuropathy · NA · enrolling by invitation
- NCT06428942 — Low-potassium Content Vegetables in Chronic Kidney Disease · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07096180 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation
- Last refreshed: 31 July 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07096180.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing